Allo-HLA reactivity of virus-specific memory T cells is common

Blood

Volumn 115, Issue 15, 2010, Pages 3146-3157

  Amir, Avital L ^a   D'Orsogna, Lloyd J A ^a   Roelen, Dave L ^a   Van Loenen, Marleen M ^a   Hagedoorn, Renate S ^a   De Boer, Renate ^a   Van Der Hoorn, Menno A W G ^a   Kester, Michel G D ^a   Doxiadis, Ilias I N ^a   Falkenburg, J H Frederik ^a   Claas, Frans H J ^a   Heemskerk, Mirjam H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CROSS REACTING ANTIBODY; EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; GENE TRANSFER; HLA SYSTEM; IMMUNOREACTIVITY; INFLUENZA VIRUS; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 77951036524     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-234906     Document Type: Article

References (45)

1. Lindahl KF, Wilson DB. Histocompatibility antigen-activated cytotoxic T lymphocytes: II, estimates of the frequency and specificity of precursors. J Exp Med. 1977;145(3):508-522. (Pubitemid 8049606)
2. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol. 2001;166(2):973-981. (Pubitemid 32060253)
3. Brondz BD, Snegirova AE. Interaction of immune lymphocytes with the mixtures of target cells possessing selected specificities of the H-2 immunizing allele. Immunology. 1971;20(4):457-468.
4. Brondz BD, Egorov IK, Drizlikh GI. Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity. J Exp Med. 1975;141(1):11-26.
5. Jones G. The number of reactive cells in mouse lymphocyte cultures stimulated by phytohemagglutinin, concanavalin A or histocompatibility antigen. J Immunol. 1973;111(3):914-920.
6. Hansen JA, Lee TD, Whitsett CF, Dupont B. Specific blocking of MLR-stimulating determinants (HLA-D) with B-cell alloantisera: preabsorption of antibody on stimulator cells. Transplant Proc. 1977;9(4):1721-1726. (Pubitemid 8256652)
7. Kalil J, Wollman EE. Role of class I and class II antigens in the allogenic stimulation: class I and class II recognition in allogenic stimulation; blocking of MLR by monoclonal antibodies and F(ab)2 fragments. Cell Immunol. 1983;79(2):367-373. (Pubitemid 13029189)
8. Nieda M, Juji T, Imao S. Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions. J Clin Invest. 1985;76(4):1477-1484. (Pubitemid 16193697)
9. Anderson G, Jenkinson EJ. Lymphostromal interactions in thymic development and function. Nat Rev Immunol. 2001;1(1):31-40. (Pubitemid 33741973)
10. Anderson G, Jenkinson WE, Jones T, et al. Establishment and functioning of intrathymic microenvironments. Immunol Rev. 2006;209:10-27.
11. Macedo C, Orkis EA, Popescu I, et al. Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant. 2009;9(9):2057-2066.
12. Chandok MR, Farber DL. Signaling control of memory T cell generation and function. Semin Immunol. 2004;16(5):285-293. (Pubitemid 39446556)
13. Farber DL, Ahmadzadeh M. Dissecting the complexity of the memory T cell response. Immunol Res. 2002;25(3):247-259. (Pubitemid 34454715)
14. Sourdive DJ, Murali-Krishna K, Altman JD, et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med. 1998;188(1):71-82. (Pubitemid 28328607)
15. Trautmann L, Rimbert M, Echasserieau K, et al. Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J Immunol. 2005;175(9):6123-6132. (Pubitemid 41508100)
16. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006;6(12):883-894. (Pubitemid 44851731)
17. van Leeuwen EM, Remmerswaal EB, Heemskerk MH, ten Berge IJ, van Lier RA. Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood. 2006;108(9):3121-3127.
18. Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med. 2002;195(7):893-905.
19. Levitsky V, de Campos-Lima PO, Frisan T, Masucci MG. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time. J Immunol. 1998;161(2):594-601. (Pubitemid 28323519)
20. Maecker HT, Maino VC. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry. Hum Immunol. 2004;65(5):493-499.
21. Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers. Virology. 1999;264(2):289-297.
22. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med. 1994;179(4):1155-1161. (Pubitemid 24091774)
23. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med. 1995;182(6):1703-1715.
24. Koelle DM, Chen HB, McClurkan CM, Petersdorf EW. Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. Blood. 2002;99(10):3844-3847.
25. Umetsu DT, Yunis EJ, Matsui Y, Jabara HH, Geha RS. HLA-DR-4-associated alloreactivity of an HLA-DR-3-restricted human tetanus toxoid-specific T cell clone: inhibition of both reactivities by an alloantiserum. Eur J Immunol. 1985;15(4):356-361. (Pubitemid 15068366)
26. Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis. 2002;2(9):539-549. (Pubitemid 34966357)
27. Heemskerk MH, de Paus RA, Lurvink EG, et al. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A. 2001;98(12):6806-6811.
28. Zoet YM, Eijsink C, Kardol MJ, et al. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies. Hum Immunol. 2005;66(5):519-525. (Pubitemid 40797550)
29. Hoogendoorn M, Olde WJ, Smit WM, et al. Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation. Clin Cancer Res. 2005;11(14):5310-5318. (Pubitemid 41003720)
30. Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen M. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood. 2009;114(17):3684-3692.
31. Burrows SR, Kienzle N, Winterhalter A, Bharadwaj M, Altman JD, Brooks A. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J Immunol. 2000;165(11):6229-6234.
32. van der Veken Hagedoorn RS, van Loenen MM, Willemze R, Falkenburg JH, Heemskerk MH. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity. Cancer Res. 2006;66(6):3331-3337.
33. D'Orsogna LJ, Amir AL, Zoet YM, et al. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire. Tissue Antigens. 2009;74(4):290-297.
34. Argaet VP, Schmidt CW, Burrows SR, et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med. 1994;180(6):2335-2340.
35. Wynn KK, Fulton Z, Cooper L, et al. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood. 2008;111(8):4283-4292.
36. Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A. Expression of two T cell receptor alpha chains: dual receptor T cells. Science. 1993;262(5132):422-424. (Pubitemid 23353384)
37. Morris GP, Allen PM. Cutting edge: highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease. J Immunol. 2009;182(11):6639-6643.
38. Felix NJ, Donermeyer DL, Horvath S, et al. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nat Immunol. 2007;8(4):388-397. (Pubitemid 46745414)
39. Rist M, Smith C, Bell MJ, Burrows SR, Khanna R. Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition. Blood. 2009;114(11):2244-2253.
40. Fischer SA. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Transplantation. 2008;86(10):1327-1339.
41. Fisher RA. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Transpl Infect Dis. 2009;11(3):195-202.
42. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601-2614.
43. Gratwohl A, Brand R, Apperley J, et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood. 2002;100(12):3877-3886. (Pubitemid 35396852)
44. Haque T, Wilkie GM, Taylor C, et al. Treatment of Epstein-Barr-virus- positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet. 2002;360(9331):436-442. (Pubitemid 34880139)
45. Haque T, Wilkie GM, Jones MM, et al. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood. 2007;110(4):1123-1131. (Pubitemid 47281407)